Changes in Intestinal Microbiota and Their Relationship With Patient Characteristics in Colorectal CancerOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
Researchers compared gut microbiota composition between 18 colorectal cancer (CRC) patients and 18 healthy controls using fecal samples collected at Northern Jiangsu People's Hospital. They asked whether microbiota differences track with clinical features like tumor stage and lymph node metastasis.
How was it studied?
Fecal samples underwent 16S rRNA gene sequencing with alpha and beta diversity analysis. PICRUSt2 software predicted differential microbial functions, and subgroup comparisons examined sex, tumor site, invasion depth, and lymph node status.
What did they find?
Firmicutes and Bacteroidetes dominated both groups, but Verrucomicrobia was significantly enriched in CRC patients (1.17% vs 0.04%). Megamonas, Lachnospira, and Romboutsia were more abundant in controls, and 18 genera differed significantly overall, linked to 21 metabolic pathways. Chao1 and observed-species diversity were lower in CRC patients. Among CRC patients with lymph node metastasis, Rothia and Streptococcus were elevated while Bacteroides, Parabacteroides, and Oscillibacter were reduced.
Why it matters
The findings suggest gut microbiota shifts, particularly Verrucomicrobia enrichment and loss of specific genera, may track with CRC development and progression, including lymph node spread. The authors note the small sample size and 16S-only approach as limitations requiring metagenomic validation.